1. Home
  2. Labeler Index
  3. West-ward Pharmaceutical Corp
  4. NDC Product Code: 0143-2120 Ergotamine

NDC 0143-2120 Ergotamine

View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. Product Characteristics
  4. What is NDC 0143-2120?
  5. Ergotamine Uses
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
0143-2120
Proprietary Name:
Ergotamine
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
West-ward Pharmaceutical Corp
Labeler Code:
0143
Product Label ID:
19479eeb-f507-48a8-bca3-c9cc0a0f6021
Start Marketing Date: [9]
09-17-2004
Listing Expiration Date: [11]
12-31-2018
Exclude Flag: [12]
I
Code Structure:
Code Navigator:

Product Characteristics

Color(s):
WHITE (C48325)
Shape:
ROUND (C48348)
Size(s):
10 MM
Imprint(s):
WW;120
Score:
1

Product Packages

NDC Code 0143-2120-01

Package Description: 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

NDC Code 0143-2120-05

Package Description: 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

NDC Code 0143-2120-30

Package Description: 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

Product Details

What is NDC 0143-2120?

The NDC code 0143-2120 is assigned by the FDA to the product Ergotamine which is product labeled by West-ward Pharmaceutical Corp. The product's dosage form is . The product is distributed in 3 packages with assigned NDC codes 0143-2120-01 100 tablet, film coated in 1 bottle, plastic , 0143-2120-05 500 tablet, film coated in 1 bottle, plastic , 0143-2120-30 30 tablet, film coated in 1 bottle, plastic . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Ergotamine?

Coadministration of ergotamine with potent CYP 3A4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, and troleandomycin) has been associated with acute ergot toxicity (ergotism) characterized by vasospasm and ischemia of the extremities (see PRECAUTIONS: Drug Interactions), with some cases resulting in amputation. There have been rare reports of cerebral ischemia in patients on protease inhibitor therapy when ergotamine tartrate and caffeine was coadministered, at least one resulting in death. Because of the increased risk for ergotism and other serious vasospastic adverse events, ergotamine use is contraindicated with these drug and other potent inhibitors of CYP 3A4 (e.g., ketoconazole, itraconazole) (see WARNINGS: CYP 3A4 Inhibitors).Ergotamine tartrate and caffeine may cause fetal harm when administered to pregnant women. Ergotamine tartrate and caffeine is contraindicated in women who are or may become pregnant. If this drug is used during pregnancy or if the patient becomes pregnant while taking this product, the patient should be apprised of the potential hazard to the fetus.Peripheral vascular disease, coronary heart disease, hypertension, impaired hepatic or renal function and sepsis.Hypersensitivity to any of the components.

Which are Ergotamine UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Ergotamine Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Ergotamine?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 1293504 - ergotamine tartrate 1 MG / caffeine 100 MG Oral Tablet
  • RxCUI: 1293504 - caffeine 100 MG / ergotamine tartrate 1 MG Oral Tablet

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".